PMID- 21852538 OWN - NLM STAT- MEDLINE DCOM- 20120228 LR - 20161125 IS - 1530-6860 (Electronic) IS - 0892-6638 (Linking) VI - 25 IP - 12 DP - 2011 Dec TI - Calsenilin regulates presenilin 1/gamma-secretase-mediated N-cadherin epsilon-cleavage and beta-catenin signaling. PG - 4174-83 LID - 10.1096/fj.11-185926 [doi] AB - Presenilin 1 (PS1) is a component of the gamma-secretase complex that cleaves a variety of type I membrane proteins, including the beta-amyloid precursor protein (beta-APP), Notch, and neuronal (N)- and epithelial (E)-cadherins. N-cadherin is an essential adhesion molecule that forms a complex with, and is cleaved by, PS1/gamma-secretase and beta-catenin in the plasma membrane. The purpose of this study was to determine whether calsenilin, a presenilin-interacting protein, has a functional role in PS1/gamma-secretase-mediated N-cadherin epsilon-cleavage using Western blot analysis, RT-PCR, immunoprecipitation, subcellular fractionation, biotinylation, and a luciferase reporter assay in SH-SY5Y neuroblastoma cells. Here, we demonstrate that the expression of calsenilin leads to a disruption of PS1/gamma-secretase-mediated epsilon-cleavage of N-cadherin, which results in the significant accumulation of N-cadherin C-terminal fragment 1 (Ncad/CTF1), the reduction of cytoplasmic Ncad/CTF2 release, and a deceleration of PS1-CTF delivery to the cell surface. Interestingly, we also found that the expression of calsenilin is associated with the redistribution of beta-catenin from the cell surface to a cytoplasmic pool, as well as with the negative regulation of genes that are targets of T-cell factor/beta-catenin nuclear signaling. Taken together, our findings suggest that calsenilin is a novel negative regulator of N-cadherin processing that plays an important role in beta-catenin signaling. FAU - Jang, Changhwan AU - Jang C AD - Ilsong Institute of Life Science, Hallym University, 1605-4 Gwanyang-dong, Dongan-gu, Anyang, Gyeonggi-do 431-060, Republic of Korea. FAU - Choi, Jin-Kyu AU - Choi JK FAU - Na, Yeo-Jung AU - Na YJ FAU - Jang, Byungki AU - Jang B FAU - Wasco, Wilma AU - Wasco W FAU - Buxbaum, Joseph D AU - Buxbaum JD FAU - Kim, Yong-Sun AU - Kim YS FAU - Choi, Eun-Kyoung AU - Choi EK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110818 PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (Antigens, CD) RN - 0 (CDH2 protein, human) RN - 0 (CTNNB1 protein, human) RN - 0 (Cadherins) RN - 0 (KCNIP3 protein, human) RN - 0 (Kv Channel-Interacting Proteins) RN - 0 (PSEN1 protein, human) RN - 0 (Presenilin-1) RN - 0 (Repressor Proteins) RN - 0 (beta Catenin) RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) RN - EC 2.7.11.26 (Glycogen Synthase Kinase 3) RN - EC 3.4.- (Amyloid Precursor Protein Secretases) SB - IM MH - Active Transport, Cell Nucleus MH - Amyloid Precursor Protein Secretases/*metabolism MH - Antigens, CD/chemistry/*metabolism MH - Cadherins/chemistry/*metabolism MH - Cell Line, Tumor MH - Cell Membrane/metabolism MH - Glycogen Synthase Kinase 3/metabolism MH - Glycogen Synthase Kinase 3 beta MH - Humans MH - Kv Channel-Interacting Proteins/genetics/*metabolism MH - Models, Neurological MH - Neuroblastoma/genetics/metabolism MH - Presenilin-1/*metabolism MH - Protein Structure, Tertiary MH - Proteolysis MH - Repressor Proteins/genetics/*metabolism MH - Signal Transduction MH - beta Catenin/genetics/*metabolism EDAT- 2011/08/20 06:00 MHDA- 2012/03/01 06:00 CRDT- 2011/08/20 06:00 PHST- 2011/08/20 06:00 [entrez] PHST- 2011/08/20 06:00 [pubmed] PHST- 2012/03/01 06:00 [medline] AID - fj.11-185926 [pii] AID - 10.1096/fj.11-185926 [doi] PST - ppublish SO - FASEB J. 2011 Dec;25(12):4174-83. doi: 10.1096/fj.11-185926. Epub 2011 Aug 18.